Cargando…

Efficacy of Magnesium Trihydrate of Ursodeoxycholic Acid and Chenodeoxycholic Acid for Gallstone Dissolution: A Prospective Multicenter Trial

BACKGROUND/AIMS: Cholecystectomy is necessary for the treatment of symptomatic or complicated gallbladder (GB) stones, but oral litholysis with bile acids is an attractive alternative therapeutic option for asymptomatic or mildly symptomatic patients. This study was conducted to evaluate the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hyun, Jong Jin, Lee, Hong Sik, Kim, Chang Duck, Dong, Seok Ho, Lee, Seung-Ok, Ryu, Ji Kon, Lee, Don Haeng, Jeong, Seok, Kim, Tae Nyeun, Lee, Jin, Koh, Dong Hee, Park, Eun Taek, Lee, Inseok, Yoo, Byung Moo, Kim, Jin Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Gut and Liver 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478000/ https://www.ncbi.nlm.nih.gov/pubmed/26087862 http://dx.doi.org/10.5009/gnl15015

Ejemplares similares

Comparison on Response and Dissolution Rates Between Ursodeoxycholic Acid Alone or in Combination With Chenodeoxycholic Acid for Gallstone Dissolution According to Stone Density on CT Scan: Strobe Compliant Observation Study
por: Lee, Jae Min, et al.
Publicado: (2015)

Efficacy of Chenodeoxycholic Acid and Ursodeoxycholic Acid Treatments for Refractory Functional Dyspepsia
por: Jang, Sung Ill, et al.
Publicado: (2022)

Developing a procedure to extract chenodeoxycholic acid and synthesize ursodeoxycholic acid from pig by-products
por: Kim, On You, et al.
Publicado: (2023)

Gallstone Decalcification and Dissolution Using Chenodeoxycholate and Citrate
por: Sali, Avni, et al.
Publicado: (1990)

Combination treatment with n-3 polyunsaturated fatty acids and ursodeoxycholic acid dissolves cholesterol gallstones in mice
por: Jang, Sung Ill, et al.
Publicado: (2019)

Enhancing Dissolution and Oral Bioavailability of Ursodeoxycholic Acid with a Spray-Dried pH-Modified Extended Release Formulation
por: Lee, Jaehyeok, et al.
Publicado: (2022)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
por: Tuncer, Ilyas, et al.
Publicado: (2012)

Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial
por: Lee, Sang Hyub, et al.
Publicado: (2020)

Efficacy and safety of a novel topical agent for gallstone dissolution: 2-methoxy-6-methylpyridine
por: Choi, Ho Joong, et al.
Publicado: (2019)

Ursodeoxycholic acid in the management of symptomatic gallstone disease: systematic review and clinician survey
por: Hall, Lewis, et al.
Publicado: (2023)

Ursodeoxycholic acid inhibits epithelial-mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An in vitro study
por: Lee, Jin, et al.
Publicado: (2022)

Ursodeoxycholic Acid Induces Death Receptor-mediated Apoptosis in Prostate Cancer Cells
por: Lee, Won Sup, et al.
Publicado: (2017)

Changes in Hepatic Gene Expression upon Oral Administration of Taurine-Conjugated Ursodeoxycholic Acid in ob/ob Mice
por: Yang, Jae-Seong, et al.
Publicado: (2010)

Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass
por: Machado, Francisco Heine Ferreira, et al.
Publicado: (2019)

Direct Effect of Chenodeoxycholic Acid on Differentiation of Mouse Embryonic Stem Cells Cultured under Feeder-Free Culture Conditions
por: Park, Soon-Jung, et al.
Publicado: (2013)

Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice
por: Kim, Ja Kyung, et al.
Publicado: (2014)

Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of Osteoarthritis
por: Yan, Zhao-wei, et al.
Publicado: (2015)

The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models
por: Fan, Ning, et al.
Publicado: (2020)

Prevention of Gallstones After Bariatric Surgery using Ursodeoxycholic Acid: A Narrative Review of Literatures
por: Son, Sang-Yong, et al.
Publicado: (2022)

Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review
por: Li, Xuan, et al.
Publicado: (2020)

Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting Endoplasmic Reticulum (ER) Stress Induced by Disturbed Flow
por: Chung, Jihwa, et al.
Publicado: (2015)

Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial
por: Min, Ju-Hong, et al.
Publicado: (2012)

Chenodeoxycholic Acid Reduces Hypoxia Inducible Factor-1α Protein and Its Target Genes
por: Moon, Yunwon, et al.
Publicado: (2015)

Ursodeoxycholic acid decreases age-related adiposity and inflammation in mice
por: Oh, Ah-Reum, et al.
Publicado: (2016)

Ursodeoxycholic acid combined with percutaneous transhepatic balloon dilation for management of gallstones after elimination of common bile duct stones
por: Chang, Hai-Yang, et al.
Publicado: (2018)

Ursodeoxycholic acid lowers bile lithogenicity by regulating SCP2 expression in rabbit cholesterol gallstone models
por: Cui, Yunfeng, et al.
Publicado: (2012)

Synergistic Inhibition of MRSA by Chenodeoxycholic Acid and Carbapenem Antibiotics
por: Cui, Kaiyu, et al.
Publicado: (2022)

Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis
por: Gong, Zizhen, et al.
Publicado: (2016)

Dielectric Breakdown and Post-Breakdown Dissolution of Si/SiO(2) Cathodes in Acidic Aqueous Electrochemical Environment
por: Yun, Jeongse, et al.
Publicado: (2018)

Gallstone, cholecystectomy and risk of gastric cancer
por: Kang, Sung Hwa, et al.
Publicado: (2017)

Gallstone prevalence and risk factors in patients with ulcerative colitis in Korean population
por: Jeong, Yo Han, et al.
Publicado: (2017)

Cerebrotendinous xanthomatosis‐associated diarrhea and response to chenodeoxycholic acid treatment
por: Brass, Eric P., et al.
Publicado: (2020)

Cerebrotendinous Xanthomatosis: diversity of presentation and refining treatment with chenodeoxycholic acid
por: Islam, Mahjabin, et al.
Publicado: (2021)

Chenodeoxycholic Acid-Amikacin Combination Enhances Eradication of Staphylococcus aureus
por: Cui, Kaiyu, et al.
Publicado: (2023)

Effect of Ursodeoxycholic Acid on the Biodistribution and Excretion of Technetium-99m Radiopharmaceuticals in Rat: A Potential Image Quality Enhancer
por: Han, Yeon-Hee, et al.
Publicado: (2021)

Anti-inflammatory effects of ursodeoxycholic acid by lipopolysaccharide-stimulated inflammatory responses in RAW 264.7 macrophages
por: Ko, Wan-Kyu, et al.
Publicado: (2017)

Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model
por: Seo, Sang Hyun, et al.
Publicado: (2022)

Biological synthesis of ursodeoxycholic acid
por: Song, Peng, et al.
Publicado: (2023)

Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction
por: Kim, Da Jung, et al.
Publicado: (2018)

Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults
por: Cariou, Bertrand, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3ifgn7bee3de2rt7mqgunfacc2